-
Loading metrics
Open Access
Peer-reviewed
Research Article
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
-
Carey K. Anders ,
* E-mail: carey_anders@med.unc.edu
Affiliations Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
Barbara Adamo ,
Contributed equally to this work with: Barbara Adamo, Olga Karginova
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Department of Human Pathology, Integrated Therapies in Oncology Unit, University of Messina, Messina, Italy
⨯ -
Olga Karginova ,
Contributed equally to this work with: Barbara Adamo, Olga Karginova
Affiliation Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
Allison M. Deal,
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Department of Biostatistics, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
Sumit Rawal,
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
David Darr,
Affiliation Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
Allison Schorzman,
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America
⨯ -
Charlene Santos,
Affiliation Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
Ryan Bash,
Affiliation Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
Tal Kafri,
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Gene Therapy Center and Department of Microbiology and Immnunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Lisa Carey,
Affiliations Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
C. Ryan Miller,
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America
⨯ -
Charles M. Perou,
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, United States of America
⨯ -
Norman Sharpless,
Affiliations Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America
⨯ -
William C. Zamboni
Affiliations Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Institute of Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
- Carey K. Anders,
- Barbara Adamo,
- Olga Karginova,
- Allison M. Deal,
- Sumit Rawal,
- David Darr,
- Allison Schorzman,
- Charlene Santos,
- Ryan Bash,
- Tal Kafri
- Published: May 1, 2013
- https://doi.org/10.1371/journal.pone.0061359